These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11696094)

  • 21. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.
    Henwood CJ; Livermore DM; Johnson AP; James D; Warner M; Gardiner A
    J Antimicrob Chemother; 2000 Dec; 46(6):931-40. PubMed ID: 11102412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci.
    Hope R; Chaudhry A; Adkin R; Livermore DM
    Int J Antimicrob Agents; 2013 Mar; 41(3):213-7. PubMed ID: 23298432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci.
    Saha V; Gupta S; Daum RS
    Infect Agents Dis; 1992 Dec; 1(6):310-8. PubMed ID: 1344669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
    Schierholz JM; Beuth J; Pulverer G
    Zentralbl Bakteriol; 1998 Dec; 288(4):527-39. PubMed ID: 9987191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2583-6. PubMed ID: 16801451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
    Jones RN; Beach ML; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):247-52. PubMed ID: 9884844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; D'Amato G; Nadolski P; Riva A; Lukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3933-6. PubMed ID: 16127075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center.
    Rodríguez JL; Vázquez GJ; Bermúdez M; De Orbeta J; García Y; Rivera Y; Robledo IE
    P R Health Sci J; 2002 Dec; 21(4):343-7. PubMed ID: 12572243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
    Wickman PA; Black JA; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.
    Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M
    P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of blood culture gram staining for the detection of Staphylococcus aureus by the 'oozing sign' surrounding clustered gram-positive cocci: a prospective observational study.
    Hadano Y; Isoda M; Ishibashi K; Kakuma T
    BMC Infect Dis; 2018 Sep; 18(1):490. PubMed ID: 30268097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging resistance in clinically important gram-positive cocci.
    Thornsberry C
    West J Med; 1996 Jan; 164(1):28-32. PubMed ID: 8779198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daptomycin susceptibility of 833 strains of Gram-positive cocci from a university hospital in Japan (2009-2011).
    Yoshizumi A; Ishii Y; Iwata M; Murakami H; Yumoto S; Yasui K; Maehara C; Fukuzawa S; Enokizono K; Tateda K
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):151-3. PubMed ID: 25056827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro brodimoprim activity on nosocomial bacterial strains.
    Nicoletti P; Novelli A; Periti P
    J Chemother; 1993 Dec; 5(6):430-4. PubMed ID: 8195834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
    Raymond J; Vedel G; Bergeret M
    J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.